Based on stimuli, this cytokine can shut-down angiogenesis inducing tumor regression (Davis et al., 2011) or promote cellular proliferation and tumor growth through activation of transcription factors such as NFκB (Hu et al., 2004). This evidence concerns the gene NFKB1 and neoplasm.